33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.94%
Revenue growth under 50% of FLNC's 131.07%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
6.95%
Gross profit growth under 50% of FLNC's 100.85%. Michael Burry would be concerned about a severe competitive disadvantage.
11.82%
EBIT growth below 50% of FLNC's 100.00%. Michael Burry would suspect deeper competitive or cost structure issues.
11.82%
Operating income growth at 50-75% of FLNC's 21.56%. Martin Whitman would doubt the firm’s ability to compete efficiently.
11.87%
Net income growth under 50% of FLNC's 25.13%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.40%
EPS growth under 50% of FLNC's 25.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
10.40%
Diluted EPS growth under 50% of FLNC's 25.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.96%
Share count expansion well above FLNC's 0.39%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.96%
Diluted share count expanding well above FLNC's 0.39%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-23.46%
Negative OCF growth while FLNC is at 78.14%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-29.47%
Negative FCF growth while FLNC is at 76.31%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
32.12%
10Y revenue/share CAGR under 50% of FLNC's 67.47%. Michael Burry would suspect a lasting competitive disadvantage.
32.12%
5Y revenue/share CAGR under 50% of FLNC's 67.47%. Michael Burry would suspect a significant competitive gap or product weakness.
32.12%
Positive 3Y CAGR while FLNC is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
117.97%
10Y OCF/share CAGR above 1.5x FLNC's 29.18%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
117.97%
5Y OCF/share CAGR above 1.5x FLNC's 29.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
117.97%
Positive 3Y OCF/share CAGR while FLNC is negative. John Neff might see a big short-term edge in operational efficiency.
29.68%
Net income/share CAGR at 50-75% of FLNC's 49.77%. Martin Whitman might question if the firm’s product or cost base lags behind.
29.68%
5Y net income/share CAGR at 50-75% of FLNC's 49.77%. Martin Whitman might see a shortfall in operational efficiency or brand power.
29.68%
Below 50% of FLNC's 78.70%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.17%
Our AR growth while FLNC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
26.59%
Inventory growth well above FLNC's 28.50%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.38%
Asset growth above 1.5x FLNC's 2.67%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.42%
Positive BV/share change while FLNC is negative. John Neff sees a clear edge over a competitor losing equity.
-6.33%
We’re deleveraging while FLNC stands at 0.21%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
4.80%
R&D dropping or stable vs. FLNC's 28.64%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.67%
SG&A declining or stable vs. FLNC's 14.01%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.